We are studying whether talazoparib can help keep mesothelioma from progressing after initial chemotherapy. This trial is for patients with advanced pleural or peritoneal mesothelioma.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced malignant mesothelioma is a type of cancer that affects the lining of the lungs (pleura) or the abdomen (peritoneum), often caused by asbestos exposure. It is characterized by aggressive growth and can lead to serious health complications.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.